Shifting the Paradigm: A New Era of Alzheimer's Clinical Trials

Webinar Overview

In this webinar you will learn about the unique aspects of conducting Alzheimer’s research from the disease complexities to patient screening. Dr. Dani Cabral and Dr. Shayne Ladak will discuss the factors that contribute to a successful study, how these trials can benefit other disease states along with research behind non-pharmacological Alzheimer’s prevention and treatment.


  1. Understand the historical challenges in Alzheimer’s research and how they have shaped current approaches.
  2. Learn the important role sites play in improving outcomes and the value they bring to Alzheimer’s clinical trials.

Meet Our Speakers

Dani Cabral, MD
Principal Investigator, IMA Clinical Research – Phoenix

Dr. Dani Cabral is a Principal Investigator at IMA Clinical Research in Phoenix. She is dual board-certified in neurology and psychiatry with a subspecialty in Alzheimer’s disease and related dementias. Dr. Cabral received her medical degree from the University of Arizona College of Medicine- Phoenix and completed residency and fellowship training at Brown University in Rhode Island. She was awarded an Alzheimer’s Association grant to increase diversity in Alzheimer’s clinical trials with the creation of a novel new role called the Alzheimer’s Equity Navigator. She serves as an industry consultant in Alzheimer’s disease and provides community and professional education. Dr. Cabral is committed to advancing Alzheimer’s science, early diagnosis, treatment and care through innovative and holistic approaches bringing together patients, families, clinicians, researchers, and communities.

Shayne Ladak, MD
Principal Investigator, IMA Clinical Research – Albuquerque

Shayne Ladak, MD, CMD is the Principal Investigator at IMA Clinical Research – Albuquerque, where he leads clinical trials for Alzheimer’s disease and other neurological conditions. He also serves as the National Medical Director — Hospice and Palliative Medicine for Curana Health and the Medical Director for Empatia Palliative Care in North Carolina and South Carolina. With medical licenses in eight US states, Dr. Ladak’s clinical expertise includes dementia, post-stroke rehabilitation, traumatic brain injury, and spinal cord injury rehab. He is a Diplomate of the American Board of Disability Analysts and a graduate of the Harvard program in Palliative Care Education and Practice.